Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,051 | Dovepress* | 7,446+ | 1,342 | 8,788 | |
PubMed Central* | 2,605 | 448 | 3,053 | ||
Totals | 10,051 | 1,790 | 11,841 | ||
*Since 5 March 2021 |
View citations on PubMed Central and Google Scholar